Published in Trends Immunol on September 03, 2013
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease. Cell (2017) 1.01
Neuro-Immune Interactions at Barrier Surfaces. Cell (2016) 0.96
The role of dendritic cells in immunity against primary herpes simplex virus infections. Front Microbiol (2014) 0.94
The influence of skin microorganisms on cutaneous immunity. Nat Rev Immunol (2016) 0.79
Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites. Hum Vaccin Immunother (2014) 0.79
An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge. PLoS One (2014) 0.77
Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy. J Tradit Complement Med (2015) 0.76
Enhancement of herpes simplex virus (HSV) infection by seminal plasma and semen amyloids implicates a new target for the prevention of HSV infection. Viruses (2015) 0.76
Ups and downs in the search for a Herpes simplex virus vaccine. Elife (2015) 0.76
Effects of Female Sex Hormones on Susceptibility to HSV-2 in Vaginal Cells Grown in Air-Liquid Interface. Viruses (2016) 0.75
CD301b+ dendritic cells stimulate tissue-resident memory CD8+ T cells to protect against genital HSV-2. Nat Commun (2016) 0.75
Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs. Front Immunol (2016) 0.75
A model of genital herpes simplex virus Type 1 infection in Rhesus Macaques. J Med Primatol (2017) 0.75
T cell exhaustion. Nat Immunol (2011) 11.08
Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science (2012) 10.47
RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell (2009) 10.11
IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol (2010) 8.97
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol (2010) 7.47
Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science (2012) 7.08
Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol (2009) 6.62
Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med (2002) 6.23
Coordination of early protective immunity to viral infection by regulatory T cells. Science (2008) 5.33
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature (2012) 4.64
Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity (2003) 4.49
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med (2000) 4.39
CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature (2009) 4.03
Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science (2008) 3.97
Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe (2010) 3.79
Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med (2007) 3.66
A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature (2012) 3.65
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ (2008) 3.62
Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature (2011) 3.38
Mucosal dendritic cells. Annu Rev Immunol (2007) 3.26
Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol (2011) 3.03
Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol (2008) 2.86
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity (2011) 2.82
Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med (2012) 2.77
Broadly neutralizing antiviral antibodies. Annu Rev Immunol (2013) 2.77
Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol (2009) 2.76
Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science (2008) 2.73
Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U S A (2012) 2.64
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet (2012) 2.54
Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection. Nature (2013) 2.38
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med (1996) 2.30
Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci U S A (2011) 2.14
Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A (2012) 2.14
Herpes simplex: insights on pathogenesis and possible vaccines. Annu Rev Med (2008) 1.99
Recognition of herpesviruses by the innate immune system. Nat Rev Immunol (2011) 1.96
Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008. MMWR Morb Mortal Wkly Rep (2010) 1.91
Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc Natl Acad Sci U S A (2012) 1.88
Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge. Virology (1998) 1.86
Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J Exp Med (2008) 1.86
Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA (2011) 1.85
Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc Natl Acad Sci U S A (2004) 1.80
Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med (2009) 1.76
Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol (2001) 1.67
Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol (2012) 1.65
Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model. Sci Transl Med (2009) 1.60
Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes. Proc Natl Acad Sci U S A (2010) 1.49
Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat Biotechnol (2011) 1.47
Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J Virol (2013) 1.46
Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol (2010) 1.45
Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol (2012) 1.40
Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16. Mucosal Immunol (2012) 1.36
Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol (2011) 1.31
HSV-2: in pursuit of a vaccine. J Clin Invest (2011) 1.29
TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest (2012) 1.24
A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe (2012) 1.21
Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. J Infect Dis (2009) 1.17
Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract. Elife (2013) 1.12
Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system. Clin Vaccine Immunol (2008) 1.12
Protective immunity against HSV-2 in the mouse vagina. J Reprod Immunol (1997) 1.10
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. Vaccine (2005) 1.09
Toll-like receptor expression in the peripheral nerve. Glia (2010) 1.08
Viral and cellular contributions to herpes simplex virus entry into the cell. Curr Opin Virol (2012) 1.08
Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infection. J Immunol (2012) 1.04
Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes. Virology (2007) 1.00
CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation. J Neurovirol (2011) 0.99
A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol (2012) 0.98
Rapid host immune response and viral dynamics in herpes simplex virus-2 infection. Nat Med (2013) 0.95
An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs. J Virol (2013) 0.95
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons. Vaccine (2011) 0.94
A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy. Vaccine (2011) 0.92
Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells. Virology (2008) 0.88
The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway. PLoS One (2013) 0.87
Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection. J Reprod Immunol (2009) 0.87
HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection. Microb Pathog (2012) 0.87
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A (2004) 9.00
Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science (2007) 7.65
Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med (2003) 7.26
Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med (2009) 5.77
Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A (2011) 5.44
CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature (2009) 4.03
Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med (2003) 3.86
Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci U S A (2009) 3.84
A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature (2012) 3.65
Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol (2010) 3.45
Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science (2010) 3.37
In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity (2010) 3.19
The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy (2007) 2.48
Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol (2002) 2.46
CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity. Immunity (2013) 2.31
Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol (2006) 1.95
CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input. Proc Natl Acad Sci U S A (2011) 1.86
Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J Exp Med (2008) 1.86
Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A (2006) 1.82
Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc Natl Acad Sci U S A (2004) 1.80
Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med (2009) 1.76
Innate control of adaptive immunity via remodeling of lymph node feed arteriole. Proc Natl Acad Sci U S A (2005) 1.62
Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells. Immunity (2012) 1.59
CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells. J Immunol (2003) 1.54
CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J Immunol (2003) 1.49
Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc Natl Acad Sci U S A (2010) 1.47
Autophagy and antiviral immunity. Curr Opin Immunol (2008) 1.44
MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice. Nat Commun (2012) 1.44
In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa. J Virol (2004) 1.39
Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol (2011) 1.38
Inflammasomes as mediators of immunity against influenza virus. Trends Immunol (2010) 1.35
IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8⁺ T cell responses to influenza A virus. Nat Immunol (2013) 1.28
Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol (2007) 1.26
A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe (2012) 1.21
Vaginal epithelial dendritic cells renew from bone marrow precursors. Proc Natl Acad Sci U S A (2007) 1.21
Tissue-resident memory T cells. Immunol Rev (2013) 1.16
A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicide. J Clin Invest (2006) 1.16
Dendritic cells at the host-pathogen interface. Nat Immunol (2006) 1.14
Autophagy and innate recognition systems. Curr Top Microbiol Immunol (2009) 1.07
MAdCAM-1 expressing sacral lymph node in the lymphotoxin beta-deficient mouse provides a site for immune generation following vaginal herpes simplex virus-2 infection. J Immunol (2004) 1.05
Toll-like receptors regulation of viral infection and disease. Adv Drug Deliv Rev (2007) 1.04
Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J Exp Med (2009) 1.03
Innate sensors of influenza virus: clues to developing better intranasal vaccines. Expert Rev Vaccines (2008) 1.01
Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I. Proc Natl Acad Sci U S A (2013) 1.00
Autophagy in the control and pathogenesis of viral infection. Curr Opin Virol (2011) 1.00
Involvement of dendritic cell subsets in the induction of oral tolerance and immunity. Ann N Y Acad Sci (2004) 0.95
ELF4 is critical for induction of type I interferon and the host antiviral response. Nat Immunol (2013) 0.95
Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev (2012) 0.93
Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node. J Immunol (2008) 0.92
Phagosome as the organelle linking innate and adaptive immunity. Traffic (2012) 0.92
Mitoxosome: a mitochondrial platform for cross-talk between cellular stress and antiviral signaling. Immunol Rev (2011) 0.92
Regulation of immature dendritic cell migration by RhoA guanine nucleotide exchange factor Arhgef5. J Biol Chem (2009) 0.89
Unique features of antiviral immune system of the vaginal mucosa. Curr Opin Immunol (2012) 0.89
Autophagic control of RLR signaling. Autophagy (2009) 0.89
Local advantage: skin DCs prime; skin memory T cells protect. Nat Immunol (2009) 0.87
Cell type-dependent requirement of autophagy in HSV-1 antiviral defense. Autophagy (2012) 0.84
Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts. Virology (2013) 0.84
Autophagy and selective deployment of Atg proteins in antiviral defense. Int Immunol (2012) 0.84
High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells. Virology (2013) 0.83
Application of the proximity-dependent assay and fluorescence imaging approaches to study viral entry pathways. Methods Mol Biol (2015) 0.83
Love triangle between Unc93B1, TLR7, and TLR9 prevents fatal attraction. Immunity (2011) 0.82
Nitric oxide and TNFα are critical regulators of reversible lymph node vascular remodeling and adaptive immune response. PLoS One (2013) 0.80
Comparative study of perceptions of work environment and moral sensitivity among Japanese and Norwegian nurses. Nurs Health Sci (2004) 0.79
Toll-like receptor 9 in plasmacytoid dendritic cells fails to detect parvoviruses. J Virol (2013) 0.78
[MHC class II-presentation of antigen by autophagy]. Tanpakushitsu Kakusan Koso (2008) 0.76
Different routes to the same destination. Elife (2013) 0.76
Skin T(RM) mediates distributed border patrol. Cell Res (2012) 0.75
[Mucosal immune defense against sexually transmitted diseases]. Nihon Rinsho (2009) 0.75
Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma. Am J Surg Pathol (2017) 0.75
[Inflammasomes in viral infection]. Uirusu (2009) 0.75
Securing mucosal borders--migrant monocytes to the rescue. Cell Host Microbe (2008) 0.75